Transforming growth factor-β1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
1993 • 1,444 citations
Peptide Growth Factors and Their Receptors
1991 • 1,221 citations
Meeting report: International autoimmune hepatitis group
1993 • 1,076 citations
Handbook of Experimental Pharmacology
1968 • 789 citations
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
1993 • 755 citations
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
1992 • 726 citations
Transforming Growth Factors β1 and α in Chronic Liver Disease
1991 • 655 citations
Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in culture
1989 • 453 citations
In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
1989 • 420 citations
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
1991 • 400 citations
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
1991 • 385 citations
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.
1990 • 311 citations
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.
1991 • 266 citations
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
1991 • 243 citations
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.
1991 • 226 citations
Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers
1995 • 219 citations
Ito–Cell Gene Expression and Collagen Regulation
1990 • 190 citations
Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta.
1991 • 145 citations
Increased transforming growth factor-β1 gene expression in human liver disease
1992 • 132 citations
Corticosteroid-Treated Chronic Active Hepatitis in Remission
1981 • 124 citations
The liver and its diseases.
1961 • 116 citations
The nature and prognosis of severe cryptogenic chronic active hepatitis
1993 • 113 citations
Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis.
1995 • 94 citations
Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
1997 • 93 citations
Autoimmunity and Liver Disease
1990 • 86 citations
The Natural Course and Heterogeneity of Autoimmune-Type Chronic Active Hepatitis
1991 • 80 citations
Regulation of Ito cell proliferation by soluble factors.
1995 • 44 citations
Evidence for spontaneous immunosuppression in autoimmune hepatitis
1995 • 32 citations
Evidence for spontaneous immunosuppression in autoimmune hepatitis*1
1995 • 6 citations
Transforming growth factor-?1 (TGF-?1) in chronic hepatitis C . Section of Hepatobillary Diseases, University of Florida, Gainesville, FL
1995 • 1 citations
Cited By (0)
No citing papers found in database